Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive approach. Advocates often emphasize the opportunity for substantial therapeutic gains, principally in ailments where conventional treatments have proven ineffective. However, this is to assess the significant financial burden associated with CPI stem cell ther